Intravitreal Bevacizumab (Avastin(®)) for Diabetic Retinopathy at 24-months: The 2008 Juan Verdaguer-Planas Lecture.
Arevalo JF, Sanchez JG, Lasave AF, Wu L, Maia M, Bonafonte S, Brito M, Alezzandrini AA, Restrepo N, Berrocal MH, Saravia M, Farah ME, Fromow-Guerra J, Morales-Canton V; Pan-American Collaborative Retina Study Group (PACORES).
Arevalo JF, et al. Among authors: wu l.
Curr Diabetes Rev. 2010 Sep;6(5):313-22. doi: 10.2174/157339910793360842.
Curr Diabetes Rev. 2010.
PMID: 20594160